Immunotherapy for cure and prophylaxis of allergic rhinitis

Clinical and Experimental Allergy Reviews

Volumn 9, Issue 1, 2009, Pages 6-10

  Nakai, Y ^a   Ohashi, Y ^b  

^a ACTY Osaka ENT Clinic   (Japan)

^b KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

Author keywords

Cure; Immunotherapy; Japanese cedar pollen; New sensitization; Prophylaxis; Seasonal allergic rhinitis

Indexed keywords

ANTIHISTAMINIC AGENT; INTERLEUKIN 4; INTERLEUKIN 5; POLLEN ANTIGEN;

ALLERGIC RHINITIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; JAPANESE CEDAR; POLLEN ALLERGY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 70350309859     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-9733.2009.01142.x     Document Type: Review

References (14)

1. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987; 79:660-677
2. Ohashi Y, Nakai Y, Tanaka A et al. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts. Acta Otolaryngol 1998; 538 (Suppl.):113-117
3. Patterson R, Lieberman P, Irons J. Immunotherapy. In: Middleton E, Reed CE, Ellis EF, eds. Allergy principles and practice. St Louis: Mosby, 1978; 877-899
4. Norman PS, Lichtenstein LM. Allergic rhinitis. In: Samter M, ed. Immunological diseases. Boston: Little Brown, 1978; 832-85
5. Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Following-up study in patients with grass pollen rhinitis. Allergy 1988; 43:523-529
6. Naclerio RM, Proud D, Moylan B et al. A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol 1997; 100:293-300.
7. Kita M, Ohmoto Y, Hirai Y et al. Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol Immunol 1992; 36:507-516
8. Nakai Y, Ohashi Y, Tanaka A et al. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens. Acta Otolaryngol 1998; 538 (Suppl.):143-151 (Pubitemid 28563336)
9. Kaneko Y, Motohashi Y, Nakamura H et al. Increasing prevalence of Japanese cedar pollinosis: a meta-regression analysis. Int Arch Allergy Immunol 2005; 136:365-371
10. Mori A, Suko M, Tsuruoka N et al. Atopic diseases and eosinophil inflammation - possible management with agents which down regulate IL-5 gene transcription. Environ Dermatol 1994; 1:42-54.
11. Till S, Dickason R, Huston D et al. IL-5 secretion by allergenstimulated CD41 T cells in primary culture: relationship toexpression of allergic diseases. J Allergy Clin Immunol 1997;99:563-569 (Pubitemid 27173096)
12. Roches AD, Paradis L, Menardo JL et al. Immunotherapy with standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitization in children. J Allergy Clin Immunol 1997; 99:450-453
13. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children. A 14-year study. Pediatrics 1968; 42:793-802.
14. Inal A, Altintas DU, Yilmaz M et al. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Invest Allergol Clin Immunol 2007; 17:85-91.